DSGN
NASDAQ
$11.87
Design Therapeutics Inc (DSGN)
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company is headquartered in Carlsbad, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $21 (+76.92%)
Market Cap
$844M
FCF 5Y CAGR
+40.70%
Free Cash Flow Yield
-6.41%
Beta (5Y)
1.13
Price Chart
Valuation
Market Cap$844M
P/S29402.82
P/B3.92
Profitability
Gross Profit (TTM)-$58M
EBITDA-$78M
EPS-$1.18
Financial Health
Free Cash Flow Yield-6.41%
Growth & Risk
FCF 5Y CAGR+40.70%
Beta (5Y)1.13
Sharpe Ratio1.69